SCHEMBL14728117

SCHEMBL14728117

CCn1c2ccccc2c2cc3c4ccc(N(c5ccc(-c6ccccc6)cc5)c5ccc6c(c5)C(C)(C)c5ccccc5-6)cc4c4ccccc4c3cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 3/20 0.36
TSPO P30536 1/20 0.36
MAPT P10636 5/20 0.36
KDM4E B2RXH2 5/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPK1 P28482 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HTT P42858 2/20 0.36
HBB P68871 1/20 0.36
LMNA P02545 3/20 0.35
RAC2 P15153 1/20 0.35
RAC3 P60763 1/20 0.35
CDC42 P60953 1/20 0.35
RAC1 P63000 1/20 0.35
KDM1A O60341 1/20 0.34
POLB P06746 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14728124 0.95 MAPT (0.38) NPY5RMAPTKDM4EMEN1KMT2A
SCHEMBL14728119 0.87 MAPT (0.34) NPY5RMAPTKDM4EMEN1KMT2A
SCHEMBL12181004 0.87 KDM4E (0.46) NPY5RTSPOMAPTKDM4EMEN1
SCHEMBL14728169 0.86 KDM4E (0.35) TSPOKDM4E
SCHEMBL21764412 0.85 PDK2 (0.36) DRD3
SCHEMBL15294272 0.85 PDK2 (0.36) DRD3
SCHEMBL19537671 0.85 PDK2 (0.36) DRD3
SCHEMBL13803358 0.85 TSPO (0.46) NPY5RTSPOMAPTKDM4EMEN1
SCHEMBL15294269 0.83 PDK2 (0.37) MAPTMEN1KMT2AHTTLMNA
SCHEMBL14461227 0.83 NPY5R (0.43) NPY5RTSPOMAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9017829-B2 Phenanthrocarbazole compound, and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2015-04-28 US disclosed
US-9017829-B2 Phenanthrocarbazole compound, and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2015-04-28 US disclosed
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2013-02-28 US disclosed
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME PPOX, ORC3, CACNA2D3 NPY5R 4298/4885TSPO 1883/4885MAPT 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.